Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:

Recent Articles

YITU Raises $15 Million for AI-Supported Cancer Diagnosis
Shanghai Exuma to Develop Conditionally Active CAR-T Candidates
Sinovant In-licenses China Rights to HGH Mimetic from Angion
Innovent's NDA Filing for Humira Biosimilar Accepted in China
LG Chem Forms IO Collaboration Worth Up to $1 Billion with Cue Biopharma
Upcoming event
ChinaBio Partnering Forum 2019
Shanghai , China
May 8-9, 2019
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

ChinaBio® Events